Caveolin-1 inhibits TrkA-induced cell death by influencing on TrkA modification associated with tyrosine-490

Eun Joo Jung1, Choong Won Kim

  • 1Department of Biochemistry, Gyeongsang National University, School of Medicine, Jinju, South Korea.

Insights

Caveolin-1 inhibits TrkA-induced cell death signaling by altering TrkA modification. This interaction suppresses Bak cleavage and apoptotic cell death, revealing a key regulatory role for caveolin-1 in cell survival pathways.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • Caveolin-1 is a structural protein of caveolae involved in signal transduction, endocytosis, and cholesterol transport.
  • Caveolin-1 has a complex role in regulating cell survival and death, influenced by intracellular signaling.
  • The receptor tyrosine kinase TrkA interacts with caveolin-1 and mediates functions in cell survival, death, and differentiation.

Purpose of the Study:

  • To investigate how caveolin-1 regulates TrkA-induced cell death signaling.
  • To examine the functional interaction between TrkA and caveolin-1 in U2OS cells overexpressing both proteins.

Main Methods:

  • Confocal immunofluorescence microscopy to observe TrkA and caveolin-1 co-localization.
  • Analysis of Bak cleavage as an indicator of cell death signaling.
  • Assessment of TrkA modifications, including tyrosine-490 phosphorylation and cleavage.

Main Results:

  • TrkA co-localizes with caveolin-1, forming aggresomes near the nucleus.
  • Caveolin-1 suppresses TrkA-mediated Bak cleavage, inhibiting TrkA-induced cell death signaling.
  • Caveolin-1 alters TrkA modifications, including tyrosine-490 phosphorylation and cleavage, leading to reduced apoptotic cell death.

Conclusions:

  • Caveolin-1 suppresses TrkA-mediated cell death signaling.
  • Functional interaction between caveolin-1 and TrkA alters TrkA modification, impacting cell death pathways.
  • Caveolin-1 plays a significant role in modulating TrkA's pleiotropic effects on cell fate.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...